Indianapolis-based Indiana University Health has become the first health system in the U.S. to administer Pixclara, a newly FDA-approved brain cancer imaging drug.
The drug is approved for use in adults and children with suspected recurrent glioma, according to an Oct. 6 news release from IU Health.
Pixclara helps physicians determine whether changes seen on imaging represent cancer recurrence or treatment effects, the release said.
The milestone is part of a broader push into theranostics at IU Health, which launched a Theranostics Center of Excellence in August, backed in part by a $20 million philanthropic gift.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
